Dec 17 (Reuters) - Pcas SA PCAS.PA :
* ANNOUNCED ON THURSDAY APPOINTMENT OF A NEW CHIEF EXECUTIVE
OFFICER
* MEETING OF THE BOARD OF DIRECTORS OF DECEMBER 16 NOTED THE
RESIGNATION OF PIERRE LUZEAU AS CHIEF EXECUTIVE OFFICER OF PCAS
* PHILIPPE CLAVEL APPOINTED CHIEF EXECUTIVE OFFICER OF PCAS
* SAID ON THURSDAY FUNDS ADVISED BY SK CAPITAL HAVE BECOME
MAJORITY SHAREHOLDERS OF SEQENS, ALONGSIDE BPI FRANCE, NOV SANTÉ
ACTIONS NON COTÉES, MÉRIEUX EQUITY PARTNERS, ARDIAN, EXIMIUM,
AND EXECUTIVE MANAGEMENT OF SEQENS
* CONCURRENT WITH THIS INVESTMENT, SEQENS HAS COMBINED WITH
WAVELENGTH PHARMACEUTICALS AND CDMO GROUP COMPANY
* SEQENS HAS ALSO DIVESTED ITS NON-CORE MINERAL SPECIALTIES
ACTIVITIES
Source text for Eikon: ID:nGNE152QRb
Further company coverage: PCAS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))